BioCentury
ARTICLE | Clinical News

Otiprio ciprofloxacin otic suspension: Phase IIIb data

September 26, 2016 7:00 AM UTC

An open-label, U.S. Phase IIIb trial in 501 patients ages 6 months to 17 years with a history of otitis media requiring tympanostomy tubes showed that a single treatment with 6 mg Otiprio in each ear ...